ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

NRXP NRX Pharmaceuticals Inc

3.80
-0.10 (-2.56%)
Fuera de horario
Última actualización: 18:15:39
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NRX Pharmaceuticals Inc NRXP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.10 -2.56% 3.80 18:15:39
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.95 3.585 3.95 3.62 3.90
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/5/202415:01PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024..
08/5/202407:30PRNUSNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in..
07/5/202415:01PRNUSNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First..
06/5/202407:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical..
30/4/202407:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising..
18/4/202407:32PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from..
18/4/202407:30PRNUSNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million..
17/4/202415:45PRNUSNRx Pharmaceuticals, Inc. Announces Proposed Underwritten..
17/4/202407:30PRNUSNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data..
15/4/202407:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of..
08/4/202407:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of..
01/4/202407:28PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and..
28/3/202407:03PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth..
28/3/202407:00PRNUSNRx Pharmaceuticals Announces Reverse Stock Split to..
26/3/202415:03PRNUSUPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth..
25/3/202407:30PRNUSNRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan..
21/3/202415:02PRNUSNRx Pharmaceuticals to Report Fourth Quarter and Full Year..
21/3/202412:57PRNUSNRx Pharmaceuticals Announces Results of the Vote Held..
12/3/202406:49PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to..
11/3/202416:16EDGAR2Form DEF 14A - Other definitive proxy statements
11/3/202407:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of..
06/3/202415:08EDGAR2Form 8-K - Current report
04/3/202407:30PRNUSNRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient,..
01/3/202407:30PRNUSNRx Pharmaceuticals Announces Definitive Purchase Agreement..
28/2/202416:09EDGAR2Form 8-K - Current report
28/2/202409:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202409:49PRNUS/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./
27/2/202407:54PRNUSNRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million..
26/2/202416:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/2/202415:01PRNUSNRx Pharmaceuticals, Inc. Announces Proposed Underwritten..
26/2/202407:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE..
20/2/202407:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE..
14/2/202415:30EDGAR2Form 8-K - Current report
14/2/202405:03EDGAR2Form 8-K - Current report
12/2/202407:30PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance..
09/2/202407:30PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by..
05/2/202405:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the..
02/2/202415:37EDGAR2Form 8-K - Current report
23/1/202415:16EDGAR2Form 8-K - Current report
22/1/202405:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces..
17/1/202405:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt..
16/1/202417:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/1/202406:25DJNNRx Pharmaceuticals Gets Fast-Track Designation for NRX-101..
16/1/202405:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA..
02/1/202407:45PRNUSNRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote..
02/1/202405:48PRNUSNRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance..
29/12/202315:30EDGAR2Form PRE 14A - Other preliminary proxy statements
29/12/202315:15EDGAR2Form 8-K - Current report
27/12/202305:48PRNUSNRx Pharmaceuticals Announces the Election of Janet..
21/12/202315:05EDGAR2Form 8-K - Current report